Canada markets close in 4 hours 24 minutes

Galmed Pharmaceuticals Ltd. (GLMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3610+0.0090 (+2.56%)
As of 11:30AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
3,569
3,569
12,995
27,220
26,082
Selling General and Administrative
3,923
3,923
4,656
5,661
4,128
Total Operating Expenses
7,492
7,492
17,651
32,881
30,210
Operating Income or Loss
-7,492
-7,492
-17,651
-32,881
-30,210
Total Other Income/Expenses Net
216
216
-490
-105
278
Income Before Tax
-6,912
-6,912
-17,866
-32,467
-28,771
Income Tax Expense
-
-
-
-
0
Income from Continuing Operations
-6,912
-6,912
-17,866
-32,467
-28,771
Net Income
-6,912
-6,912
-17,866
-32,467
-28,771
Net Income available to common shareholders
-6,912
-6,912
-17,866
-32,467
-28,771
Basic EPS
-3.02
-
-10.65
-19.80
-20.25
Diluted EPS
-3.02
-
-10.65
-19.80
-20.25
Basic Average Shares
2,832
-
1,676
1,640
1,419
Diluted Average Shares
2,832
-
1,676
1,640
1,419